phrykt

Electra Therapeutics, Inc. (ETRA): who owns it and who trades it

As of Nov 16, 2026, ETRA insiders reported 18 purchases worth $24.3M in the last 12 months. The largest buyer was Carl L Gordon (Director), with $20M. 5 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Electra Therapeutics

From the latest filings

Overall: more buying than selling. Insiders and famous investors mostly bought.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Insider trades

In the last 12 months, ETRA insiders reported $24.3M of open-market purchases and $0 of sales.

Purchases, 12 months
$24.3M
18 trades, 2 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
Nov 10, 2026
Filed Nov 10, 2026

Purchases and sales by month

$20M$20MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 10, 2026Orbimed Advisors Llc +2DirectorPurchase20,700$8.45$175KForm 4
Nov 10, 2026Orbimed Advisors Llc +2DirectorPurchase2,000$8.45$16.9KForm 4
Nov 9, 2026Orbimed Advisors Llc +2DirectorPurchase4,000$8.24$33KForm 4
Nov 9, 2026Orbimed Advisors Llc +2DirectorPurchase16,000$8.24$132KForm 4
Nov 6, 2026Orbimed Advisors Llc +2DirectorPurchase9,816$7.85$77.1KForm 4
Nov 6, 2026Orbimed Advisors Llc +2DirectorPurchase39,600$7.85$311KForm 4
Nov 5, 2026Orbimed Advisors Llc +2DirectorPurchase30,891$7.31$226KForm 4
Nov 5, 2026Orbimed Advisors Llc +2DirectorPurchase125,200$7.31$915KForm 4
Nov 4, 2026Orbimed Advisors Llc +2DirectorPurchase9,267$7.78$72.1KForm 4
Nov 4, 2026Orbimed Advisors Llc +2DirectorPurchase37,100$7.78$289KForm 4
Nov 4, 2026Orbimed Advisors Llc +2DirectorPurchase5,000$7.07$35.4KForm 4
Nov 4, 2026Orbimed Advisors Llc +2DirectorPurchase20,000$7.07$141KForm 4
Nov 3, 2026Orbimed Advisors Llc +2DirectorPurchase24,313$7.84$191KForm 4
Nov 3, 2026Orbimed Advisors Llc +2DirectorPurchase97,800$7.84$767KForm 4
Nov 3, 2026Orbimed Advisors Llc +2DirectorPurchase24,400$7.88$192KForm 4
Nov 3, 2026Orbimed Advisors Llc +2DirectorPurchase98,600$7.88$777KForm 4
Sep 21, 2026Carl L GordonDirectorPurchase333,333$15.00$5MForm 4
Sep 21, 2026Carl L GordonDirectorPurchase1.00M$15.00$15MForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Carl L GordonDirector, 10% owner$20M–Sep 21, 2026
Orbimed Advisors LlcDirector, 10% owner$4.3M–Nov 10, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

ETRA short interest

484,020 ETRA shares are sold short. Over the last 3 reports the number of shares short went down 31%.

As of Oct 30, 2026, 484,020 ETRA shares were sold short, up 18.2% from the report before. At the average daily volume of 285,287 shares, buying them all back would take about 1.7 trading days (days to cover).

Shares short

484,020Sep 30Oct 30746,199

Days to cover

1.7Sep 30Oct 301.8

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 2026484,020–+18%285,2871.7
Oct 15, 2026409,380–-42%516,1071.0
Sep 30, 2026702,266––909,4921.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Electra Therapeutics company events

Electra Therapeutics filed 1 report on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Sep 21, 2026.

  1. Sep 21, 2026AnnouncementThe Company closed its IPO of an aggregate of 23,333,334 shares of common stock at a price to the public of $15.00 per share. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Famous investors that hold ETRA

5 of the 50 well-known investors we track reported holding ETRA in their latest 13F filing. The largest position is Israel Englander's, worth $4.1M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Israel Englander · Millennium ManagementQ3 2026368,373$4.1M0.0%New
Ken Griffin · Citadel AdvisorsQ3 2026145,584$1.6M0.0%New
George Soros · Soros Fund ManagementQ3 202675,000$844K0.0%New
Steve Cohen · Point72 Asset ManagementQ3 202647,005$529K0.0%New
Paul Tudor Jones · Tudor Investment CorpQ3 202613,354$150K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named ETRA in the last 120 days.

FiledHolderFormStake
Nov 16, 2026Cormorant Asset Management, LP13G5.4%
Nov 16, 2026Cormorant Asset Management, LP13G5.4%
Oct 29, 2026Westlake BioPartners Fund I, L.P.13G5.6%
Oct 29, 2026Westlake BioPartners Fund I, L.P.13G5.6%

Questions about Electra Therapeutics, Inc. (ETRA) stock

Are ETRA insiders buying or selling?

In the last 12 months, ETRA insiders reported 18 open-market purchases worth $24.3M and no sales. The latest trade was on Nov 10, 2026. See every trade.

What is the short interest in ETRA?

As of Oct 30, 2026, 484,020 ETRA shares were sold short, up 18.2% from the report before. At the average daily volume of 285,287 shares, buying them all back would take about 1.7 trading days (days to cover). See the history.

Which famous investors hold ETRA?

5 of the 50 well-known investors we track reported ETRA in their latest 13F filing, including Israel Englander, Ken Griffin, George Soros. The largest position is worth $4.1M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.